Research Article

Major depressive disorder diagnosis from electroencephalogram data and potential treatment with dimethyltryptamine

Volume: 7 Number: 2 August 15, 2023
EN

Major depressive disorder diagnosis from electroencephalogram data and potential treatment with dimethyltryptamine

Abstract

In recent times, there has been increasing interest in utilizing EEG-based techniques for studying Major Depressive Disorder as a dynamic method. Although it is frequently used for identifying depression, the method is still difficult to interpret. The conventional treatment of MDD involves medications such as Selective Serotonin Reuptake Inhibitors, which often have adverse effects. On the other hand, the use of dimethyltryptamine to stimulate brain activity in regions where MDD patients show lower activity has demonstrated promising results. This study analyzed resting-state EEG signals from MDD patients, DMT users, and healthy controls to evaluate and validated a computer-aided approach. The brain activity of DMT users was recorded and compared with MDD individuals and healthy controls. Using Welch's method, the power of several frequency bands was analyzed from the EEG dataset for comparison and diagnosis. The extracted EEG data underwent noise removal and feature extraction. The features from all controls were concatenated to form a data matrix. Furthermore, the data matrix was standardized using the Z-score standardization method. The classifier model logistic regression was employed to train and test the extracted features. The results of the investigations have demonstrated the most important features, such as signal power of the EEG data from the frontal, temporal, parietal, and occipital brain areas, to be significant.

Keywords

References

  1. 1. Depressive disorder (depression). [2023 March 31]; Available from https://www.who.int/news-room/fact-sheets/detail/depression.
  2. 2. Park K, Jaekal E, Yoon S, Lee S-H and Choi K-H, Diagnostic Utility and Psychometric Properties of the Beck Depression Inventory-II Among Korean Adults. Frontiers in Psychology, 2020. 10: 2934.
  3. 3. Gu S, Wang F, Cao C, Wu E, Tang Y-Y and Huang JH, An Integrative Way for Studying Neural Basis of Basic Emotions With fMRI. Frontiers in Neuroscience, 2019. 13: 628.
  4. 4. Mayberg, H. S., Frontal lobe dysfunction in secondary depression. The Journal of Neuropsychiatry and Clinical Neurosciences, 1994. 6(4): p. 428–442.
  5. 5. Timmermann, C., Roseman, L., Schartner, M., Milliere, R., Williams, L. T. J., Erritzoe, D., Muthukumaraswamy, S., Ashton, M., Bendrioua, A., Kaur, O., Turton, S., Nour, M. M., Day, C. M., Leech, R., Nutt, D. J., and Carhart-Harris, R. L., Neural correlates of the DMT experience assessed with multivariate EEG. Scientific Reports, 2019. 9(1): 16324.
  6. 6. Duan L, Duan H, Qiao Y, Sha S, Qi S, Zhang X, Huang J, Huang X and Wang C, Machine Learning Approaches for MDD Detection and Emotion Decoding Using EEG Signals. Frontiers in Human Neuroscience, 2020. 14: 284.
  7. 7. Sperandei, S., Understanding logistic regression analysis. Biochemia Medica, 2014. 24(1): p. 12–18.
  8. 8. Tariq, M., Trivailo, P. M., & Simic, M., EEG-based BCI control schemes for lower-limb assistive-robots. Frontiers in Human Neuroscience, 2018. 12: 312.

Details

Primary Language

English

Subjects

Computer Software, Software Engineering (Other), Biomedical Engineering

Journal Section

Research Article

Early Pub Date

August 27, 2023

Publication Date

August 15, 2023

Submission Date

January 8, 2023

Acceptance Date

August 1, 2023

Published in Issue

Year 2023 Volume: 7 Number: 2

APA
Jahan, S. (2023). Major depressive disorder diagnosis from electroencephalogram data and potential treatment with dimethyltryptamine. International Advanced Researches and Engineering Journal, 7(2), 90-96. https://doi.org/10.35860/iarej.1231288
AMA
1.Jahan S. Major depressive disorder diagnosis from electroencephalogram data and potential treatment with dimethyltryptamine. Int. Adv. Res. Eng. J. 2023;7(2):90-96. doi:10.35860/iarej.1231288
Chicago
Jahan, Sushmit. 2023. “Major Depressive Disorder Diagnosis from Electroencephalogram Data and Potential Treatment With Dimethyltryptamine”. International Advanced Researches and Engineering Journal 7 (2): 90-96. https://doi.org/10.35860/iarej.1231288.
EndNote
Jahan S (August 1, 2023) Major depressive disorder diagnosis from electroencephalogram data and potential treatment with dimethyltryptamine. International Advanced Researches and Engineering Journal 7 2 90–96.
IEEE
[1]S. Jahan, “Major depressive disorder diagnosis from electroencephalogram data and potential treatment with dimethyltryptamine”, Int. Adv. Res. Eng. J., vol. 7, no. 2, pp. 90–96, Aug. 2023, doi: 10.35860/iarej.1231288.
ISNAD
Jahan, Sushmit. “Major Depressive Disorder Diagnosis from Electroencephalogram Data and Potential Treatment With Dimethyltryptamine”. International Advanced Researches and Engineering Journal 7/2 (August 1, 2023): 90-96. https://doi.org/10.35860/iarej.1231288.
JAMA
1.Jahan S. Major depressive disorder diagnosis from electroencephalogram data and potential treatment with dimethyltryptamine. Int. Adv. Res. Eng. J. 2023;7:90–96.
MLA
Jahan, Sushmit. “Major Depressive Disorder Diagnosis from Electroencephalogram Data and Potential Treatment With Dimethyltryptamine”. International Advanced Researches and Engineering Journal, vol. 7, no. 2, Aug. 2023, pp. 90-96, doi:10.35860/iarej.1231288.
Vancouver
1.Sushmit Jahan. Major depressive disorder diagnosis from electroencephalogram data and potential treatment with dimethyltryptamine. Int. Adv. Res. Eng. J. 2023 Aug. 1;7(2):90-6. doi:10.35860/iarej.1231288

Cited By



Creative Commons License

Any further distribution of this work must maintain attribution to the author(s) and the title of the work, journal citation and DOI.